Neurodon is a biotechnology company focused on treating cellular stress through the development of disease-modifying therapeutics. Their proprietary small molecules target the SERCA enzyme to restore calcium balance in cells, addressing conditions such as diabetes, Alzheimer’s, Parkinson’s, and Duchenne muscular dystrophy. With a unique approach that has been in research for decades, Neurodon aims to revolutionize medicine by providing effective treatments that alleviate cellular stress. The company is currently in preclinical development and has formed partnerships to advance its innovative therapies, positioning itself as a leader in the market with no direct competitors targeting the same mechanisms of action.
Is this your company?
Something looks off?